Form 8-K NovaBay Pharmaceuticals, For: Apr 10StreetInsider.comPioneer Singapore participated in the Private Placement, purchasing 2,590,000 Units for an aggregate purchase price of $1,554,000, receiving therefor 2,590,000 Shares, Long-Term Warrants to purchase 1,942,500 shares of the Company’s common stock, … and more …read more
Form 8-K NovaBay Pharmaceuticals, For: Apr 10 – StreetInsider.com Read More »
EveryWare Global, Inc. Announces Fourth Quarter 2014 Results; Begins 2015 …CNNMoneyIn exchange for the cancellation of all (a) shares of our current outstanding common stock and (b) outstanding vested options or unexercised warrants to acquire shares of our current outstanding stock as of the Petition Date that are in each case “in … and more
EveryWare Global, Inc. Announces Fourth Quarter 2014 Results; Begins 2015 … – CNNMoney Read More »
Nobilis Health Corp. Announces Accelerated Expiry Date of WarrantsSatellite PR News (press release)HOUSTON, TX–(Marketwired – Apr 14, 2015) – Nobilis Health Corp. (TSX: NHC) (“Nobilis” or the “Company”) today announced that it has elected to accelerate the expiry date of the common share purchase warrants (the “Warrants”) originally issued by … and more …read more
Berkowitz’s Fairholme Partnership Up 8.3% In Q1FINalternativesSuch securities may include preferred and common stock, bank debt, convertible securities and bonds, warrants, and interests in real estate investment trusts. The portfolio shifts across asset classes and market sectors based upon Fairholme’s … and more …read more
Berkowitz’s Fairholme Partnership Up 8.3% In Q1 – FINalternatives Read More »
The Fairholme Partnership Delivers 8.3% Net Return In 1Q 2015ValueWalkSuch securities may include preferred and common stock, bank debt, convertible securities and bonds, warrants, and interests in real estate investment trusts. The Partnership’s portfolio shifts across asset classes and market sectors based upon … and more …read more
The Fairholme Partnership Delivers 8.3% Net Return In 1Q 2015 – ValueWalk Read More »
The Fairholme Partnership Delivers 8.3% Net Return in 1Q 2015MarketWatchSuch securities may include preferred and common stock, bank debt, convertible securities and bonds, warrants, and interests in real estate investment trusts. The Partnership’s portfolio shifts across asset classes and market sectors based upon … and more …read more
The Fairholme Partnership Delivers 8.3% Net Return in 1Q 2015 – MarketWatch Read More »
The Fairholme Partnership Delivers 8.3% Net Return in 1Q 2015Insurance News NetSuch securities may include preferred and common stock, bank debt, convertible securities and bonds, warrants, and interests in real estate investment trusts. The Partnership’s portfolio shifts across asset classes and market sectors based upon … and more …read more
The Fairholme Partnership Delivers 8.3% Net Return in 1Q 2015 – Insurance News Net Read More »
Notable Mergers and AcquisitionsStreetInsider.comIn connection with the offering, Cipher has issued Athyrium 600,000 common share purchase warrants. The warrants are exercisable at US$9.22 (equal to the five-day volume-weighted average price on the Toronto Stock Exchange prior to closing converted … …read more
Notable Mergers and Acquisitions – StreetInsider.com Read More »
ValueWalkLast February we warned about Resonant Inc (NASDAQ:RESN) and since then the stock has fallen over 70%. We believe CorMedix has many of the same attributes that alarmed us about RESN. We believe CRMD is wildly overvalued, is poised for a big drop … …read more
Resonant Down 70%… Could CorMedix Inc. (CRMD) Be Next? – ValueWalk Read More »
Cipher Pharmaceuticals announces U.S. commercial entry through acquisition of …Military TechnologiesIn connection with the offering, Cipher has issued Athyrium 600,000 common share purchase warrants. The warrants are exercisable at US$9.22 (equal to the five-day volume-weighted average price on the Toronto Stock Exchange prior to closing converted … and more …read more